ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,035.69
-1.57%
US Tech 100
16,920.00
-2.25%
다우존스 지수
37,815.92
-1.49%
Bitcoin
60,628.69
-5.02%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Celldex Therapeutics Inc (CLDX)

  7. Celldex Therapeutics Inc (CLDX) 뉴스

CLDX Celldex Therapeutics Inc

37.42
0.42 (1.14%)
시간외 거래
최종 업데이트: 06:50:49
15분 지연
기업명 주식 심볼 시장 주식 타입
Celldex Therapeutics Inc CLDX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.42 1.14% 37.42 06:50:49
개장가 저가 고가 종가 전일 종가
36.74 36.35 38.15 37.42 37.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202421:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
08/03/202421:00GLOBECelldex Therapeutics to Participate in the Leerink Partners..
06/03/202400:30GLOBECelldex Therapeutics to Present at TD Cowen’s 44th Annual..
06/03/202400:10GLOBECelldex Therapeutics Announces Closing of Public Offering of..
02/03/202406:10EDGAR2Form 8-K - Current report
02/03/202406:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/03/202411:14GLOBECelldex Therapeutics Announces Pricing of Upsized $400..
29/02/202406:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/02/202406:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
26/02/202422:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/02/202421:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/02/202421:01EDGAR2Form 8-K - Current report
26/02/202421:01GLOBECelldex Reports Fourth Quarter and Year End 2023 Financial..
25/02/202404:05GLOBECelldex Therapeutics Presents Positive 12 Week Results from..
16/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202402:52EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202401:48EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202421:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202423:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/02/202400:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202406:01GLOBECelldex to Participate in the Guggenheim Healthcare Talks..
05/02/202422:01GLOBECelldex Announces Upcoming Presentation of Barzolvolimab..
05/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:15GLOBECelldex Therapeutics to Present at 6th Annual Evercore ISI..
21/11/202306:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/11/202307:03EDGAR2Form 8-K - Current report
09/11/202307:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/11/202313:15GLOBECelldex Therapeutics Announces Pricing of Public Offering of..
08/11/202306:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/11/202306:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
06/11/202323:00EDGAR2Form 8-K - Current report
06/11/202320:30GLOBECelldex Therapeutics Announces Positive Topline Results from..
06/11/202305:00GLOBECelldex Therapeutics Presents Positive Data from Prurigo..
04/11/202305:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:01EDGAR2Form 8-K - Current report
03/11/202305:01GLOBECelldex Reports Third Quarter 2023 Financial Results and..
26/09/202320:01GLOBECelldex Announces Acceptance of Abstract for Barzolvolimab..
25/09/202321:31GLOBECelldex Therapeutics to Present at Cantor Global Healthcare..
09/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:01EDGAR2Form 8-K - Current report
09/08/202305:01GLOBECelldex Reports Second Quarter 2023 Financial Results and..
11/07/202321:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
06/07/202321:01GLOBECelldex Announces First Patient Dosed in Phase 2 Study of..
10/06/202323:45GLOBECelldex Therapeutics Presents Positive Data from..
09/06/202305:01GLOBECelldex Therapeutics Announces Upcoming Barzolvolimab..
02/06/202321:01GLOBECelldex Therapeutics to Present at Jefferies Healthcare..
31/05/202321:01GLOBECelldex Announces First Patient Dosed in Phase 1 Study of..
15/05/202321:01GLOBECelldex Therapeutics Presents Positive Preclinical Data from..

최근 히스토리

NASDAQ
CLDX
Celldex Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유